Becton Dickinson and Co. has named its diabetes spinoff Embecta. The Franklin Lakes, NJ-based company’s board approved the spin-off, which is set to occur April 1.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,